Business Daily presenter Ed Butler reports from California, at the Future In Review conference which is an annual gathering of business pioneers. He speaks to a genetics expert Dr. Lee Hood about a new plan for medical treatment which, he believes, will revolutionize the application and the cost of healthcare.
Renowned scientist Dr. Leroy Hood spoke casually with North Central High School students about mitochondrial DNA and planning for a future in science as he toured the school’s Institute of Science and Technology where students are immersed in molecular biology.
“A lot of this science didn’t exist when I was a kid,” said Hood, 81. “I’ve spent most of my career working with kids. It’s nice to connect.”
We’re getting a better idea of how longtime Microsoft executive Craig Mundie is going to spend some of his time after he retires from the software giant next year.
Mundie, the former chief research and strategy officer at Microsoft who now serves as an advisor to Steve Ballmer, was just named to the board of the Institute for Systems Biology.
“Sequestration” has forced the National Institutes of Health – the leading funder of biomedical research – to halt or cut funding to thousands of potentially groundbreaking research projects. On the 10th Anniversary of the completion of the Human Genome Project, we can’t let the ongoing tug-of-war in Congress over spending priorities threaten the revolutionary work that is taking place in medical science. Quite the opposite, recent advances in science and medicine have the potential to reduce healthcare’s drain on the federal budget and spur economic growth.
ISB associate professor Nathan Price and Evangelos Simeonidis, a visiting scholar from Luxembourg Centre for Systems Biomedicine (LCSB is a major strategic partner with ISB), contributed to this paper – “A community-driven global reconstruction of human metabolism”